Teleflex Incorporated (TFX) is a publicly traded Healthcare sector company. As of November 5, 2026, TFX trades at $150.29 with a market cap of $5.93B and a P/E ratio of -5.46. TFX moved +0.28% today. Year to date, TFX is +20.45%; over the trailing twelve months it is +20.50%. Its 52-week range spans $100.18 to $149.93. Analyst consensus is buy with an average price target of $155.88. Rallies surfaces TFX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Teleflex Q3 adjusted EPS beats estimates as outlook holds and units grow: Teleflex reported Q3 revenue of $567.78 million, up 0.2% year over year and slightly above estimates, while adjusted diluted EPS of $2.63 beat the $1.90 consensus. It raised adjusted EPS guidance, maintained its pro forma adjusted constant-currency revenue growth outlook and lowered GAAP revenue growth guidance, citing foreign exchange changes.
| Metric | Value |
|---|---|
| Price | $150.29 |
| Market Cap | $5.93B |
| P/E Ratio | -5.46 |
| EPS | $-23.31 |
| Dividend Yield | 0.34% |
| 52-Week High | $149.93 |
| 52-Week Low | $100.18 |
| Volume | 207 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.25B |
| Net Income | $-1.03B |
| Gross Margin | 54.94% |
8 analysts cover TFX: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $155.88.